 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Peak Bio, Inc. (NASDAQ:PKBO  Get Rating) shares shot up 36.8% during mid-day trading on Friday . The stock traded as high as $7.59 and last traded at $6.50. 529,309 shares changed hands during trading, an increase of 172% from the average session volume of 194,357 shares. The stock had ...

Peak Bio (NASDAQ:PKBO) Trading 36.8% Higher

Gainers
Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08.

read more...

Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session

Newly public Peak Bio stock rallies 27% in wake of SPAC merger

Peak Bio, Inc. ('Peak Bio' or the 'Company') (NASDAQ: PKBO), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases, today announced that it has entered into a Common Stock Purchase...

Peak Bio, Inc. Announces Closing of up to $100 Million Common Stock Purchase Transaction with White Lion Capital

Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease. The company is headquartered in Pleasanton, CA.

Watchers	186
52-Wk Low	$0.036
52-Wk High	$7.16

Market Cap	$1.88M
Volume (M)	113.00
52-Wk High	$7.16
52-Wk Low	$0.036

PKBO Ignyte Acquisition Corp

About

Feed

News

Sentiment

Fundamentals